Rhabdomyolysis associated with cerivastatin: Six cases within 3 months at one hospital

Pharmacotherapy

Volumn 22, Issue 6, 2002, Pages 771-774

  Lucas, Robert A ^a   Weathersby, B Blake ^b   Rocco, Vito K ^a   Pepper, J Michael ^a   Butler, Kerry L ^a  

^a SAINT THOMAS HOSPITAL   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERIVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CREATINE KINASE; PYRIDINE DERIVATIVE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DRUG SAFETY; FEMALE; HEMODIALYSIS; HUMAN; MALE; RHABDOMYOLYSIS; BLOOD; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; FATALITY; KIDNEY FAILURE; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

AGED; CASE REPORT; CREATINE KINASE; DRUG INTERACTIONS; FATAL OUTCOME; FEMALE; HUMAN; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY FAILURE; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGE; PYRIDINES; RENAL DIALYSIS; RHABDOMYOLYSIS; HUMANS; MIDDLE AGED;

EID: 0036014890     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.9.771.34071     Document Type: Article

References (9)

1. Cerivastatin
2. Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy
3. Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin
4. Cerivastatin-induced rhabdomyolysis
5. FDA adverse event reports on statin-associated rhabdomyolysis
6. Cerivastatin and reports of fatal rhabdomyolysis
7. Cerivastatin and gemfibrozil-associated rhabdomyolysis